Norinchukin Bank, The Vertex Pharmaceuticals Inc Transaction History

Norinchukin Bank, The

  • $4.18 Billion
  • Q3 2024

A detailed history of Norinchukin Bank, The transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Norinchukin Bank, The holds 12,851 shares of VRTX stock, worth $5.26 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
12,851
Previous 11,135 15.41%
Holding current value
$5.26 Million
Previous $5.22 Million 14.5%
% of portfolio
0.14%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$460.0 - $505.78 $789,360 - $867,918
1,716 Added 15.41%
12,851 $5.98 Million
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $1,964 - $2,427
5 Added 0.04%
11,135 $5.22 Million
Q1 2024

May 14, 2024
SELL
$407.69 - $446.08 $96,622 - $105,720
-237 Reduced 2.08%
11,130 $4.65 Million
Q4 2023

Feb 13, 2024
SELL
$343.0 - $410.68 $569,037 - $681,318
-1,659 Reduced 12.74%
11,367 $4.63 Million
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $4.41 Million - $4.72 Million
13,026 New
13,026 $4.53 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $2.08 Million - $2.33 Million
6,622 Added 32.77%
26,829 $9.44 Million
Q1 2023

May 12, 2023
BUY
$283.23 - $323.1 $147,846 - $168,658
522 Added 2.65%
20,207 $6.37 Million
Q4 2022

Feb 13, 2023
SELL
$285.76 - $321.48 $1.25 Million - $1.41 Million
-4,391 Reduced 18.24%
19,685 $5.68 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $667,597 - $744,882
2,438 Added 11.27%
24,076 $6.97 Million
Q2 2022

Aug 10, 2022
SELL
$234.96 - $292.55 $1.11 Million - $1.38 Million
-4,719 Reduced 17.9%
21,638 $6.1 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $549,564 - $647,727
2,482 Added 10.4%
26,357 $6.88 Million
Q4 2021

Feb 10, 2022
SELL
$177.01 - $223.45 $339,682 - $428,800
-1,919 Reduced 7.44%
23,875 $5.24 Million
Q3 2021

Nov 09, 2021
BUY
$181.39 - $202.99 $253,764 - $283,983
1,399 Added 5.73%
25,794 $4.68 Million
Q2 2021

Aug 11, 2021
BUY
$187.49 - $221.1 $40,685 - $47,978
217 Added 0.9%
24,395 $4.92 Million
Q1 2021

May 12, 2021
BUY
$207.02 - $241.31 $234,967 - $273,886
1,135 Added 4.93%
24,178 $5.2 Million
Q4 2020

Feb 12, 2021
SELL
$207.01 - $276.09 $27,325 - $36,443
-132 Reduced 0.57%
23,043 $5.45 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $198,895 - $235,811
778 Added 3.47%
23,175 $6.31 Million
Q2 2020

Aug 12, 2020
BUY
$225.48 - $295.8 $2,029 - $2,662
9 Added 0.04%
22,397 $6.5 Million
Q1 2020

May 13, 2020
SELL
$199.77 - $247.81 $2.48 Million - $3.08 Million
-12,421 Reduced 35.68%
22,388 $5.33 Million
Q4 2019

Feb 12, 2020
SELL
$166.71 - $223.91 $501,463 - $673,521
-3,008 Reduced 7.95%
34,809 $7.62 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $166,894 - $187,838
1,004 Added 2.73%
37,817 $6.41 Million
Q2 2019

Aug 09, 2019
SELL
$164.61 - $190.37 $2.05 Million - $2.37 Million
-12,442 Reduced 25.26%
36,813 $6.75 Million
Q1 2019

May 10, 2019
BUY
$163.73 - $194.7 $282,597 - $336,052
1,726 Added 3.63%
49,255 $9.06 Million
Q4 2018

Feb 08, 2019
BUY
$151.91 - $192.21 $2.23 Million - $2.82 Million
14,658 Added 44.59%
47,529 $7.88 Million
Q3 2018

Nov 08, 2018
BUY
$167.73 - $192.74 $670,584 - $770,574
3,998 Added 13.85%
32,871 $6.34 Million
Q2 2018

Aug 10, 2018
BUY
$145.72 - $169.96 $817,197 - $953,135
5,608 Added 24.1%
28,873 $4.91 Million
Q1 2018

May 10, 2018
BUY
$151.6 - $177.13 $461,773 - $539,537
3,046 Added 15.07%
23,265 $3.79 Million
Q4 2017

Feb 09, 2018
BUY
$137.28 - $155.55 $199,605 - $226,169
1,454 Added 7.75%
20,219 $3.03 Million
Q3 2017

Nov 08, 2017
BUY
$148.13 - $162.24 $2.78 Million - $3.04 Million
18,765
18,765 $2.85 Million

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email